Drug Trial Radar · NCT05681351
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
Last checked: Nov 20, 2026Latest source record: Dec 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
885
Actual
Start
Dec 13, 2022
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Jan 12, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
Conditions
- Severe Hypertriglyceridemia
Interventions
OlezarsenDrug
Administered as SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants With Change in Clinical Laboratory Values From Baseline to Week 53, From Baseline to Week 105, and From Baseline to Week 157Time frame: Baseline up to Week 157
- Proportion of Participants Who Experience Adverse Events (AEs)Time frame: Baseline up to Week 157
- Proportion of Participants Who Use Concomitant MedicationsTime frame: Baseline up to Week 157
Locations
262 sites in 33 countries. Site status is shown where the registry gives one.
LA Universal Research Center, Inc.
Los Angeles, California
University of California, San Diego (UCSD)
San Diego, California
Metabolic Institute of America
Tarzana, California
Excel Medical Clinical Trials
Boca Raton, Florida
Finlay Medical Research
Greenacres City, Florida
Columbus Clinical Services, LLC
Miami, Florida
Finlay Medical Research
Miami, Florida
Innovia Research Center, Inc.
Miramar, Florida
Harmony Clinical Research, Inc.
North Miami Beach, Florida
R & B Medical Center LLC
Tampa, Florida
VICIS Clinical Research
Tampa, Florida
JSV Clinical Research Study, Inc.
Tampa, Florida
Bayside Clinical Research
Trinity, Florida
Centricity Research
Columbus, Georgia
IACT Health
Columbus, Georgia
Affinity Health
Oak Brook, Illinois
St. Vincent Medical Group, Inc.
Carmel, Indiana
University of Kansas Medical Center (KUMC)
Kansas City, Kansas
The Research Group of Lexington, LLC
Lexington, Kentucky
Louisville Metabolic and Atherosclerosis Research Center (L-MARC)
Louisville, Kentucky
Grace Research, LLC
Bossier City, Louisiana
University of Maryland School of Medicine
Baltimore, Maryland
IRC Clinics
Towson, Maryland
Massachusetts General Hospital Heart Center
Boston, Massachusetts
University of Michigan- Endocrinology & Metabolism
Ann Arbor, Michigan
Aa Mrc, Llc
Flint, Michigan
Washington School of Medicine
St Louis, Missouri
Bryan Medical Center
Lincoln, Nebraska
Palm Research Center, Inc.
Las Vegas, Nevada
Hudson County Clinical Trials Research Center
Union City, New Jersey
Modern Medical
Brooklyn, New York
NYU Langone Health
Mineola, New York
Langone Medical Center
New York, New York
Vagelos College of Physicians and Surgeons of Columbia University
New York, New York
Orchard Park Family Practice
Orchard Park, New York
The Presbyterian Hospital DBA Novant Health Heart and Vascular Institute
Charlotte, North Carolina
Kenneth Hilty
Greensboro, North Carolina
Clinical Trials of America, LLC
Lenoir, North Carolina
Lexington
Winston-Salem, North Carolina
The Ohio State University
Columbus, Ohio
Showing 40 of 262 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.